Research Vision
Our aims for the future
Research Vision
Our aims for the future
A core-funded Institute
The CRUK Manchester Institute is a leading cancer research institute within The University of Manchester, spanning the whole spectrum of cancer research – from investigating the molecular and cellular basis of cancer, to translational research and the development of therapeutics.
We are one of Cancer Research UK’s core-funded institutes which means the majority of our research is supported by the public, something which is always at the front of our minds. We are incredibly grateful for this support and offer fundraisers the opportunity to visit the Institute on our open days.
Team Science
The Institute comprises over 350 Postdoctoral Scientists, Clinical Fellows, Scientific Officers, Operational and Technical staff, Postgraduate Research Students and Visiting Fellows and we pride ourselves on being as much a community as a workplace. We have cutting edge laboratory facilities and outstanding core services, including genomic sequencing, confocal microscopy, bioinformatics, histology, and access to mass-spectrometry based proteomics.
Get in touch
Colocation promotes collaboration and innovation – Research Vision
Our new research facility supports our ambitions of integrated basic and clinical translational cancer research. It brings together a critical mass of scientists and clinicians on The Christie NHS Foundation Trust site to collaborate and accelerate progress for patients through integrated advances in the prevention, early detection and treatment of cancer.
The new 9-storey Paterson building, opened in Spring 2023, contains our world leading Cancer Biomarker Centre, provides state-of-the-art equipment and facilities, and alongside the Oglesby Cancer Research Building makes us one of the top cancer research centres in the world.